ID: ALA5208153

Max Phase: Preclinical

Molecular Formula: C15H12N2O3

Molecular Weight: 268.27

Associated Items:

Representations

Canonical SMILES:  COc1ccc(NC(=O)c2noc3ccccc23)cc1

Standard InChI:  InChI=1S/C15H12N2O3/c1-19-11-8-6-10(7-9-11)16-15(18)14-12-4-2-3-5-13(12)20-17-14/h2-9H,1H3,(H,16,18)

Standard InChI Key:  ZZMUAPXMNXWVOV-UHFFFAOYSA-N

Associated Targets(Human)

Hypoxia-inducible factor 1 alpha 6027 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 268.27Molecular Weight (Monoisotopic): 268.0848AlogP: 3.09#Rotatable Bonds: 3
Polar Surface Area: 64.36Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.98CX Basic pKa: CX LogP: 2.68CX LogD: 2.68
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.79Np Likeness Score: -1.46

References

1. Xue Z, Li H, Xie W, Xu Y, Zhou L, Qu ZB..  (2022)  Benzo[d]isoxazole Derivatives as Hypoxia-Inducible Factor (HIF)-1α Inhibitors.,  13  (12.0): [PMID:36518694] [10.1021/acsmedchemlett.2c00308]

Source